Postmenopausal Hormone Management is the specialized clinical practice of assessing and treating the systemic endocrine changes that occur following the cessation of ovarian function, primarily characterized by a significant decline in estrogen and progesterone production. This management involves personalized strategies, often including bioidentical hormone replacement therapy (BHRT), to alleviate vasomotor symptoms, preserve bone mineral density, and mitigate cardiovascular and neurocognitive risks associated with hormone deficiency. It is a critical component of female longevity care.
Origin
This clinical discipline is a direct evolution of hormone replacement therapy (HRT) following menopause, with modern management shifting towards a nuanced, risk-stratified approach informed by large-scale clinical trials and observational data. The term emphasizes ongoing, individualized care rather than a single, static treatment.
Mechanism
Management operates by introducing exogenous estrogen and progesterone to target tissues with specific receptors, such as the uterus, bone, and brain. The therapeutic mechanism aims to restore a physiological hormonal environment to maintain homeostasis. Estrogen acts to prevent bone resorption and improve endothelial function, while progesterone is often co-administered to protect the endometrium from unopposed estrogenic stimulation, ensuring a balanced and safe intervention.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.